Genotype-Epigenotype Interaction at the IGF2 DMR
AbstractPaternally expressed Insulin-like Growth Factor II (IGF2) encodes a gene whose protein product functions as a potent growth mitogen. Overexpression of IGF2 has been implicated in a wide number of disorders and diseases. IGF2 is regulated in part by differential methylation of the two parentally derived alleles. The differentially methylated region (DMR) located upstream of the imprinted promoters of IGF2 exhibits plasticity under environmental stress and is hypomethylated in several types of cancer. Through bisulfite pyrosequencing and confirmation by nucleotide sequencing, we discovered a CpG to CpC transversion that results in hypomethylation of one of the three CpGs comprising this DMR. The presence of the polymorphism introduces a genetic rather than an environmentally-driven epigenetic source of hypomethylation that is additive to non-genetic sources. View Full-Text
Share & Cite This Article
Murphy, S.K.; Erginer, E.; Huang, Z.; Visco, Z.; Hoyo, C. Genotype-Epigenotype Interaction at the IGF2 DMR. Genes 2015, 6, 777-789.
Murphy SK, Erginer E, Huang Z, Visco Z, Hoyo C. Genotype-Epigenotype Interaction at the IGF2 DMR. Genes. 2015; 6(3):777-789.Chicago/Turabian Style
Murphy, Susan K.; Erginer, Erin; Huang, Zhiqing; Visco, Zachary; Hoyo, Cathrine. 2015. "Genotype-Epigenotype Interaction at the IGF2 DMR." Genes 6, no. 3: 777-789.